39830-63-2 Usage
General Description
3-Hydroxy-4-nitroisoindolin-1-one, also known as 3-hydroxy-4-nitro-1H-isoindol-1-one, is a chemical compound with the molecular formula C8H5NO4. It is a highly reactive and versatile compound that is often used as a building block in the synthesis of pharmaceuticals, dyes, and other organic compounds. It is a yellow crystalline powder with a melting point of 159-163°C and is soluble in organic solvents such as acetone, chloroform, and ethyl acetate. The compound has been studied for its potential antimicrobial and anticancer properties, and its chemical structure makes it a valuable intermediate for the production of various organic compounds. Additionally, it is also used as a reagent in organic synthesis and has applications in the field of medicinal chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 39830-63-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,9,8,3 and 0 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 39830-63:
(7*3)+(6*9)+(5*8)+(4*3)+(3*0)+(2*6)+(1*3)=142
142 % 10 = 2
So 39830-63-2 is a valid CAS Registry Number.
39830-63-2Relevant articles and documents
PI3K-α INHIBITORS AND METHODS OF USE THEREOF
-
Paragraph 0890, (2021/11/06)
The present disclosure relates to novel compounds and pharmaceutical compositions thereof, and methods for inhibiting the activity of PI3K-α enzymes with the compounds and compositions of the disclosure. The present disclosure further relates to, but is n
ROCK KINASE INHIBITORS
-
Paragraph 0223-0225, (2020/05/29)
The present invention relates to compounds that inhibit ROCK activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of inhibiting ROCK activity and methods for treating, for example cerebral cavernous malformation syndrome (CCM) and cardiovascular diseases using the compounds and pharmaceutical compositions of the present invention.
